Angel Investments
Oncology-focused clinical trials enabler Mestastop raises $500-K
Bengaluru-based Mestastop Solutions has raised INR 4.5 crore (USD 500,000) in a Pre-Series-A funding round led by 92 Angels and Malpani Ventures. The funds will be used to generate ‘proof of concept' data with small molecules around the identified targets and also help progress drug repurposing efforts to delay metastasis by identifying probable clinical candidates. The new models and clinical studies will also be supported with strategic business development activities. Founded by Arnab Roy Chowdhury and Debabani Roy Chowdhury, Mestastop claims to be creating a cancer metastasis focussed platform, which would use wet lab biology and predictive analytics to identify and distinguish unique properties of metastasis and leverage them for drug discovery and patient treatment. In 2021, the firm had attracted a seed funding of INR 2 crore led by IIM Ahmedabad's CIIE with participation from IKP and angel investors.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
